{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,10]],"date-time":"2026-10-10T11:19:15Z","timestamp":1791631155643,"version":"4.3.4"},"reference-count":67,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2018,3,1]],"date-time":"2018-03-01T00:00:00Z","timestamp":1519862400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2018,3,1]],"date-time":"2018-03-01T00:00:00Z","timestamp":1519862400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2017,11,29]],"date-time":"2017-11-29T00:00:00Z","timestamp":1511913600000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Brain, Behavior, and Immunity"],"published-print":{"date-parts":[[2018,3]]},"DOI":"10.1016\/j.bbi.2017.11.020","type":"journal-article","created":{"date-parts":[[2017,12,2]],"date-time":"2017-12-02T05:53:31Z","timestamp":1512194011000},"page":"264-272","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":116,"special_numbering":"C","title":["Association between a functional interleukin 6 receptor genetic variant and risk of depression and psychosis in a population-based birth cohort"],"prefix":"10.1016","volume":"69","author":[{"given":"Golam M.","family":"Khandaker","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Stanley","family":"Zammit","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Stephen","family":"Burgess","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Glyn","family":"Lewis","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Peter B.","family":"Jones","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.bbi.2017.11.020_b0005","series-title":"Diagnostic and statistical manual of mental disorders","author":"APA","year":"2013"},{"key":"10.1016\/j.bbi.2017.11.020_b0010","doi-asserted-by":"crossref","first-page":"379","DOI":"10.1093\/ije\/dyv108","article-title":"Mendelian randomization: where are we now and where are we going?","volume":"44","author":"Burgess","year":"2015","journal-title":"Int. J. Epidemiol."},{"key":"10.1016\/j.bbi.2017.11.020_b0015","doi-asserted-by":"crossref","first-page":"720","DOI":"10.1038\/nrrheum.2014.127","article-title":"IL-6 biology: implications for clinical targeting in rheumatic disease","volume":"10","author":"Calabrese","year":"2014","journal-title":"Nat. Rev. Rheumatol."},{"key":"10.1016\/j.bbi.2017.11.020_b0020","doi-asserted-by":"crossref","first-page":"1205","DOI":"10.1016\/S0140-6736(11)61931-4","article-title":"Interleukin-6 receptor pathways in coronary heart disease: a collaborative meta-analysis of 82 studies","volume":"379","author":"Collaboration","year":"2012","journal-title":"Lancet"},{"key":"10.1016\/j.bbi.2017.11.020_b0025","doi-asserted-by":"crossref","first-page":"588","DOI":"10.1038\/nature14659","article-title":"Sparse whole-genome sequencing identifies two loci for major depressive disorder","volume":"523","author":"Converge Consortium","year":"2015","journal-title":"Nature"},{"key":"10.1016\/j.bbi.2017.11.020_b0030","doi-asserted-by":"crossref","first-page":"782","DOI":"10.1192\/bjp.150.6.782","article-title":"Detection of postnatal depression. Development of the 10-item Edinburgh Postnatal Depression Scale","volume":"150","author":"Cox","year":"1987","journal-title":"Br. J. Psychiatr. J. Mental Sci."},{"key":"10.1016\/j.bbi.2017.11.020_b0035","doi-asserted-by":"crossref","first-page":"e78","DOI":"10.1371\/journal.pmed.0050078","article-title":"Long-term interleukin-6 levels and subsequent risk of coronary heart disease: two new prospective studies and a systematic review","volume":"5","author":"Danesh","year":"2008","journal-title":"PLoS Med."},{"key":"10.1016\/j.bbi.2017.11.020_b0040","doi-asserted-by":"crossref","first-page":"399","DOI":"10.1016\/j.ejphar.2004.07.040","article-title":"Cytokine-induced sickness behaviour: a neuroimmune response to activation of innate immunity","volume":"500","author":"Dantzer","year":"2004","journal-title":"Eur. J. Pharmacol."},{"key":"10.1016\/j.bbi.2017.11.020_b0045","doi-asserted-by":"crossref","first-page":"46","DOI":"10.1038\/nrn2297","article-title":"From inflammation to sickness and depression: when the immune system subjugates the brain","volume":"9","author":"Dantzer","year":"2008","journal-title":"Nat. Rev. Neurosci."},{"key":"10.1016\/j.bbi.2017.11.020_b0050","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1093\/ije\/dyg070","article-title":"\u2018Mendelian randomization\u2019: can genetic epidemiology contribute to understanding environmental determinants of disease?","volume":"32","author":"Davey Smith","year":"2003","journal-title":"Int. J. Epidemiol."},{"key":"10.1016\/j.bbi.2017.11.020_b0055","doi-asserted-by":"crossref","first-page":"446","DOI":"10.1016\/j.biopsych.2009.09.033","article-title":"A meta-analysis of cytokines in major depression","volume":"67","author":"Dowlati","year":"2010","journal-title":"Biol. Psychiatr."},{"key":"10.1016\/j.bbi.2017.11.020_b0060","doi-asserted-by":"crossref","first-page":"e1003444","DOI":"10.1371\/journal.pgen.1003444","article-title":"Functional IL6R 358Ala allele impairs classical IL-6 receptor signaling and influences risk of diverse inflammatory diseases","volume":"9","author":"Ferreira","year":"2013","journal-title":"PLoS Genet."},{"key":"10.1016\/j.bbi.2017.11.020_b0065","doi-asserted-by":"crossref","first-page":"413","DOI":"10.1017\/S0033291708003723","article-title":"Associations of C-reactive protein and interleukin-6 with cognitive symptoms of depression: 12-year follow-up of the Whitehall II study","volume":"39","author":"Gimeno","year":"2009","journal-title":"Psychol. Med."},{"key":"10.1016\/j.bbi.2017.11.020_b0070","doi-asserted-by":"crossref","DOI":"10.1038\/mp.2016.3","article-title":"A meta-analysis of blood cytokine network alterations in psychiatric patients: comparisons between schizophrenia, bipolar disorder and depression","author":"Goldsmith","year":"2016","journal-title":"Mol. Psychiatr."},{"key":"10.1016\/j.bbi.2017.11.020_b0075","doi-asserted-by":"crossref","first-page":"581","DOI":"10.1111\/j.1469-7610.1997.tb01545.x","article-title":"The Strengths and Difficulties Questionnaire: a research note","volume":"38","author":"Goodman","year":"1997","journal-title":"J. Child Psychol. Psychiatr. Allied Disciplines"},{"key":"10.1016\/j.bbi.2017.11.020_b0080","first-page":"664","article-title":"Fatigue in rheumatoid arthritis: quantitative findings on the efficacy of tocilizumab and on factors associated with fatigue. The French multicentre prospective PEPS Study","volume":"33","author":"Gossec","year":"2015","journal-title":"Clin. Exp. Rheumatol."},{"key":"10.1016\/j.bbi.2017.11.020_b0085","doi-asserted-by":"crossref","first-page":"1016","DOI":"10.1038\/mp.2009.49","article-title":"The bipolar disorder risk allele at CACNA1C also confers risk of recurrent major depression and of schizophrenia","volume":"15","author":"Green","year":"2010","journal-title":"Mol. Psychiatr."},{"key":"10.1016\/j.bbi.2017.11.020_b0090","doi-asserted-by":"crossref","first-page":"206","DOI":"10.1016\/j.bbi.2015.06.001","article-title":"Cumulative meta-analysis of interleukins 6 and 1beta, tumour necrosis factor alpha and C-reactive protein in patients with major depressive disorder","volume":"49","author":"Haapakoski","year":"2015","journal-title":"Brain Behav. Immun."},{"key":"10.1016\/j.bbi.2017.11.020_b0095","doi-asserted-by":"crossref","first-page":"407","DOI":"10.1016\/j.biopsych.2009.03.015","article-title":"Inflammation causes mood changes through alterations in subgenual cingulate activity and mesolimbic connectivity","volume":"66","author":"Harrison","year":"2009","journal-title":"Biol. Psychiatr."},{"key":"10.1016\/j.bbi.2017.11.020_b0100","doi-asserted-by":"crossref","first-page":"3707","DOI":"10.1093\/eurheartj\/ehs354","article-title":"Interleukin-6 receptor pathways in abdominal aortic aneurysm","volume":"34","author":"Harrison","year":"2013","journal-title":"Eur. Heart J."},{"key":"10.1016\/j.bbi.2017.11.020_b0105","doi-asserted-by":"crossref","first-page":"16136","DOI":"10.1073\/pnas.1415191111","article-title":"Individual differences in the peripheral immune system promote resilience versus susceptibility to social stress","volume":"111","author":"Hodes","year":"2014","journal-title":"PNAS"},{"key":"10.1016\/j.bbi.2017.11.020_b0110","doi-asserted-by":"crossref","first-page":"171","DOI":"10.1097\/PSY.0b013e3181907c1b","article-title":"Associations of depression with C-reactive protein, IL-1, and IL-6: a meta-analysis","volume":"71","author":"Howren","year":"2009","journal-title":"Psychosom. Med."},{"key":"10.1016\/j.bbi.2017.11.020_b0115","unstructured":"Hudson, Z.D., Miller, B.J., 2016. Meta-analysis of cytokine and chemokine genes in schizophrenia. Clin. Schizophrenia Related Psychoses."},{"key":"10.1016\/j.bbi.2017.11.020_b0120","first-page":"243","article-title":"Cardiometabolic effects of genetic upregulation of the interleukin 1 receptor antagonist: a Mendelian randomisation analysis. The lancet","volume":"3","author":"Interleukin 1 Genetics Consortium","year":"2015","journal-title":"Diab. Endocrinol."},{"key":"10.1016\/j.bbi.2017.11.020_b0130","doi-asserted-by":"crossref","first-page":"775","DOI":"10.1017\/S0033291797005308","article-title":"The National Psychiatric Morbidity surveys of Great Britain\u2013initial findings from the household survey","volume":"27","author":"Jenkins","year":"1997","journal-title":"Psychol. Med."},{"key":"10.1016\/j.bbi.2017.11.020_b0135","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.schres.2015.10.008","article-title":"Association study of functional polymorphisms in interleukins and interleukin receptors genes: IL1A, IL1B, IL1RN, IL6, IL6R, IL10, IL10RA and TGFB1 in schizophrenia in Polish population","volume":"169","author":"Kapelski","year":"2015","journal-title":"Schizophrenia Res."},{"key":"10.1016\/j.bbi.2017.11.020_b0140","article-title":"Antidepressant activity of anti-cytokine treatment: a systematic review and meta-analysis of clinical trials of chronic inflammatory conditions","author":"Kappelmann","year":"2016","journal-title":"Mol. Psychiatr."},{"key":"10.1016\/j.bbi.2017.11.020_b0145","doi-asserted-by":"crossref","first-page":"1559","DOI":"10.1007\/s00213-015-3975-1","article-title":"Is there a role for immune-to-brain communication in schizophrenia?","volume":"233","author":"Khandaker","year":"2016","journal-title":"Psychopharmacology"},{"key":"10.1016\/j.bbi.2017.11.020_b0150","doi-asserted-by":"crossref","first-page":"1121","DOI":"10.1001\/jamapsychiatry.2014.1332","article-title":"Association of serum interleukin 6 and C-reactive protein in childhood with depression and psychosis in young adult life: a population-based longitudinal study","volume":"71","author":"Khandaker","year":"2014","journal-title":"JAMA Psychiatr."},{"key":"10.1016\/j.bbi.2017.11.020_b0155","first-page":"1","article-title":"Childhood inflammatory markers and intelligence as predictors of subsequent persistent depressive symptoms: a longitudinal cohort study","author":"Khandaker","year":"2017","journal-title":"Psychol. Med."},{"key":"10.1016\/j.bbi.2017.11.020_b0160","doi-asserted-by":"crossref","first-page":"1381","DOI":"10.1001\/jamapsychiatry.2014.1611","article-title":"Effect of anti-inflammatory treatment on depression, depressive symptoms, and adverse effects: a systematic review and meta-analysis of randomized clinical trials","volume":"71","author":"Kohler","year":"2014","journal-title":"JAMA Psychiatr."},{"key":"10.1016\/j.bbi.2017.11.020_b0165","doi-asserted-by":"crossref","first-page":"9009","DOI":"10.1038\/srep09009","article-title":"STAT3 controls IL6-dependent regulation of serotonin transporter function and depression-like behavior","volume":"5","author":"Kong","year":"2015","journal-title":"Sci. Rep."},{"key":"10.1016\/j.bbi.2017.11.020_b0170","doi-asserted-by":"crossref","first-page":"207","DOI":"10.1136\/jech.48.2.207","article-title":"Assessing psychiatric disorder with a human interviewer or a computer","volume":"48","author":"Lewis","year":"1994","journal-title":"J. Epidemiol. Commun. Health"},{"key":"10.1016\/j.bbi.2017.11.020_b0175","doi-asserted-by":"crossref","first-page":"465","DOI":"10.1017\/S0033291700030415","article-title":"Measuring psychiatric disorder in the community: a standardized assessment for use by lay interviewers","volume":"22","author":"Lewis","year":"1992","journal-title":"Psychol. Med."},{"key":"10.1016\/j.bbi.2017.11.020_b0180","doi-asserted-by":"crossref","first-page":"853","DOI":"10.1006\/cyto.1997.0238","article-title":"Increased serum IL-6 and IL-1 receptor antagonist concentrations in major depression and treatment resistant depression","volume":"9","author":"Maes","year":"1997","journal-title":"Cytokine"},{"key":"10.1016\/j.bbi.2017.11.020_b0185","doi-asserted-by":"crossref","unstructured":"Major Depressive Disorder Working Group of the Psychiatric, G.C., Ripke, S., Wray, N.R., Lewis, C.M., Hamilton, S.P., Weissman, M.M., Breen, G., Byrne, E.M., Blackwood, D.H., Boomsma, D.I., Cichon, S., Heath, A.C., Holsboer, F., Lucae, S., Madden, P.A., Martin, N.G., McGuffin, P., Muglia, P., Noethen, M.M., Penninx, B.P., Pergadia, M.L., Potash, J.B., Rietschel, M., Lin, D., Muller-Myhsok, B., Shi, J., Steinberg, S., Grabe, H.J., Lichtenstein, P., Magnusson, P., Perlis, R.H., Preisig, M., Smoller, J.W., Stefansson, K., Uher, R., Kutalik, Z., Tansey, K.E., Teumer, A., Viktorin, A., Barnes, M.R., Bettecken, T., Binder, E.B., Breuer, R., Castro, V.M., Churchill, S.E., Coryell, W.H., Craddock, N., Craig, I.W., Czamara, D., De Geus, E.J., Degenhardt, F., Farmer, A.E., Fava, M., Frank, J., Gainer, V.S., Gallagher, P.J., Gordon, S.D., Goryachev, S., Gross, M., Guipponi, M., Henders, A.K., Herms, S., Hickie, I.B., Hoefels, S., Hoogendijk, W., Hottenga, J.J., Iosifescu, D.V., Ising, M., Jones, I., Jones, L., Jung-Ying, T., Knowles, J.A., Kohane, I.S., Kohli, M.A., Korszun, A., Landen, M., Lawson, W.B., Lewis, G., Macintyre, D., Maier, W., Mattheisen, M., McGrath, P.J., McIntosh, A., McLean, A., Middeldorp, C.M., Middleton, L., Montgomery, G.M., Murphy, S.N., Nauck, M., Nolen, W.A., Nyholt, D.R., O'Donovan, M., Oskarsson, H., Pedersen, N., Scheftner, W.A., Schulz, A., Schulze, T.G., Shyn, S.I., Sigurdsson, E., Slager, S.L., Smit, J.H., Stefansson, H., Steffens, M., Thorgeirsson, T., Tozzi, F., Treutlein, J., Uhr, M., van den Oord, E.J., Van Grootheest, G., Volzke, H., Weilburg, J.B., Willemsen, G., Zitman, F.G., Neale, B., Daly, M., Levinson, D.F., Sullivan, P.F., 2013. A mega-analysis of genome-wide association studies for major depressive disorder. Mol. Psychiatr. 18, 497\u2013511.","DOI":"10.1038\/mp.2012.21"},{"key":"10.1016\/j.bbi.2017.11.020_b0190","doi-asserted-by":"crossref","first-page":"732","DOI":"10.1016\/j.biopsych.2008.11.029","article-title":"Inflammation and its discontents: the role of cytokines in the pathophysiology of major depression","volume":"65","author":"Miller","year":"2009","journal-title":"Biol. Psychiatr."},{"key":"10.1016\/j.bbi.2017.11.020_b0195","doi-asserted-by":"crossref","first-page":"663","DOI":"10.1016\/j.biopsych.2011.04.013","article-title":"Meta-analysis of cytokine alterations in schizophrenia: clinical status and antipsychotic effects","volume":"70","author":"Miller","year":"2011","journal-title":"Biol. Psychiatr."},{"key":"10.1016\/j.bbi.2017.11.020_b0200","first-page":"1","article-title":"C-Reactive protein levels in schizophrenia","author":"Miller","year":"2013","journal-title":"Clin. Schizophrenia Related Psychoses"},{"key":"10.1016\/j.bbi.2017.11.020_b0205","doi-asserted-by":"crossref","first-page":"275","DOI":"10.4088\/JCP.15l09920","article-title":"An open-label, pilot trial of adjunctive tocilizumab in schizophrenia","volume":"77","author":"Miller","year":"2016","journal-title":"J. Clin. Psychiatr."},{"key":"10.1016\/j.bbi.2017.11.020_b0210","doi-asserted-by":"crossref","first-page":"1162","DOI":"10.1093\/schbul\/sbv028","article-title":"Cortisol and inflammatory biomarkers predict poor treatment response in first episode psychosis","volume":"41","author":"Mondelli","year":"2015","journal-title":"Schizophrenia Bull."},{"key":"10.1016\/j.bbi.2017.11.020_b0215","doi-asserted-by":"crossref","first-page":"1029","DOI":"10.1176\/appi.ajp.159.6.1029","article-title":"Beneficial antipsychotic effects of celecoxib add-on therapy compared to risperidone alone in schizophrenia","volume":"159","author":"Muller","year":"2002","journal-title":"Am. J. Psychiatr."},{"key":"10.1016\/j.bbi.2017.11.020_b0220","doi-asserted-by":"crossref","first-page":"884","DOI":"10.1016\/j.jaac.2010.06.008","article-title":"Meta-analysis of genome-wide association studies of attention-deficit\/hyperactivity disorder","volume":"49","author":"Neale","year":"2010","journal-title":"J. Am. Acad. Child Adolesc. Psychiatry"},{"key":"10.1016\/j.bbi.2017.11.020_b0225","doi-asserted-by":"crossref","first-page":"326","DOI":"10.1016\/j.jpsychires.2006.05.013","article-title":"Plasma cytokine profiles in depressed patients who fail to respond to selective serotonin reuptake inhibitor therapy","volume":"41","author":"O'Brien","year":"2007","journal-title":"J. Psychiatr. Res."},{"key":"10.1016\/j.bbi.2017.11.020_b0230","doi-asserted-by":"crossref","first-page":"511","DOI":"10.1038\/sj.mp.4002148","article-title":"Lipopolysaccharide-induced depressive-like behavior is mediated by indoleamine 2,3-dioxygenase activation in mice","volume":"14","author":"O'Connor","year":"2009","journal-title":"Mol. Psychiatry"},{"key":"10.1016\/j.bbi.2017.11.020_b0235","doi-asserted-by":"crossref","first-page":"801","DOI":"10.1016\/j.biopsych.2007.09.024","article-title":"Inflammatory cytokine alterations in schizophrenia: a systematic quantitative review","volume":"63","author":"Potvin","year":"2008","journal-title":"Biol. Psychiatry"},{"key":"10.1016\/j.bbi.2017.11.020_b0240","doi-asserted-by":"crossref","unstructured":"Power, R.A., Tansey, K.E., Buttenschon, H.N., Cohen-Woods, S., Bigdeli, T., Hall, L.S., Kutalik, Z., Lee, S.H., Ripke, S., Steinberg, S., Teumer, A., Viktorin, A., Wray, N.R., Arolt, V., Baune, B.T., Boomsma, D.I., Borglum, A.D., Byrne, E.M., Castelao, E., Craddock, N., Craig, I.W., Dannlowski, U., Deary, I.J., Degenhardt, F., Forstner, A.J., Gordon, S.D., Grabe, H.J., Grove, J., Hamilton, S.P., Hayward, C., Heath, A.C., Hocking, L.J., Homuth, G., Hottenga, J.J., Kloiber, S., Krogh, J., Landen, M., Lang, M., Levinson, D.F., Lichtenstein, P., Lucae, S., MacIntyre, D.J., Madden, P., Magnusson, P.K., Martin, N.G., McIntosh, A.M., Middeldorp, C.M., Milaneschi, Y., Montgomery, G.W., Mors, O., Muller-Myhsok, B., Nyholt, D.R., Oskarsson, H., Owen, M.J., Padmanabhan, S., Penninx, B.W., Pergadia, M.L., Porteous, D.J., Potash, J.B., Preisig, M., Rivera, M., Shi, J., Shyn, S.I., Sigurdsson, E., Smit, J.H., Smith, B.H., Stefansson, H., Stefansson, K., Strohmaier, J., Sullivan, P.F., Thomson, P., Thorgeirsson, T.E., Van der Auwera, S., Weissman, M.M., Converge Consortium, C.C.G.C., Breen, G., Lewis, C.M., 2017. Genome-wide association for major depression through age at onset stratification: major depressive disorder working group of the psychiatric genomics consortium Biol. Psychiatry 81, 325\u2013335.","DOI":"10.1016\/j.biopsych.2016.05.010"},{"key":"10.1016\/j.bbi.2017.11.020_b0245","doi-asserted-by":"crossref","first-page":"327","DOI":"10.1001\/jama.286.3.327","article-title":"C-reactive protein, interleukin 6, and risk of developing type 2 diabetes mellitus","volume":"286","author":"Pradhan","year":"2001","journal-title":"JAMA J. Am. Med. Assoc."},{"key":"10.1016\/j.bbi.2017.11.020_b0250","doi-asserted-by":"crossref","first-page":"24","DOI":"10.1016\/j.it.2005.11.006","article-title":"Cytokines sing the blues: inflammation and the pathogenesis of depression","volume":"27","author":"Raison","year":"2006","journal-title":"Trends Immunol."},{"key":"10.1016\/j.bbi.2017.11.020_b0255","doi-asserted-by":"crossref","first-page":"31","DOI":"10.1001\/2013.jamapsychiatry.4","article-title":"A randomized controlled trial of the tumor necrosis factor antagonist infliximab for treatment-resistant depression: the role of baseline inflammatory biomarkers","volume":"70","author":"Raison","year":"2013","journal-title":"JAMA Psychiatry"},{"key":"10.1016\/j.bbi.2017.11.020_b0260","doi-asserted-by":"crossref","first-page":"716","DOI":"10.1086\/513206","article-title":"Admixture mapping of an allele affecting interleukin 6 soluble receptor and interleukin 6 levels","volume":"80","author":"Reich","year":"2007","journal-title":"Am. J. Human Genet."},{"key":"10.1016\/j.bbi.2017.11.020_b0265","doi-asserted-by":"crossref","first-page":"445","DOI":"10.1001\/archpsyc.58.5.445","article-title":"Cytokine-associated emotional and cognitive disturbances in humans","volume":"58","author":"Reichenberg","year":"2001","journal-title":"Arch. Gen. Psychiatry"},{"key":"10.1016\/j.bbi.2017.11.020_b0270","doi-asserted-by":"crossref","first-page":"421","DOI":"10.1038\/nature13595","article-title":"Biological insights from 108 schizophrenia-associated genetic loci","volume":"511","author":"Schizophrenia Working Group of the Psychiatric Genomics, C.","year":"2014","journal-title":"Nature"},{"key":"10.1016\/j.bbi.2017.11.020_b0275","doi-asserted-by":"crossref","first-page":"557","DOI":"10.1161\/CIRCGENETICS.110.959197","article-title":"Large-scale candidate gene analysis in whites and African Americans identifies IL6R polymorphism in relation to atrial fibrillation: the National Heart, Lung, and Blood Institute's Candidate Gene Association Resource (CARe) project","volume":"4","author":"Schnabel","year":"2011","journal-title":"Circulation Cardiovas. Genet."},{"key":"10.1016\/j.bbi.2017.11.020_b0280","doi-asserted-by":"crossref","first-page":"749","DOI":"10.1038\/mp.2016.49","article-title":"Genome-wide analysis of over 106 000 individuals identifies 9 neuroticism-associated loci","volume":"21","author":"Smith","year":"2016","journal-title":"Mol. Psychiatry"},{"key":"10.1016\/j.bbi.2017.11.020_b0285","doi-asserted-by":"crossref","first-page":"181","DOI":"10.1093\/schbul\/sbt139","article-title":"Efficacy of anti-inflammatory agents to improve symptoms in patients with schizophrenia: an update","volume":"40","author":"Sommer","year":"2014","journal-title":"Schizophrenia Bull."},{"key":"10.1016\/j.bbi.2017.11.020_b0290","doi-asserted-by":"crossref","first-page":"479","DOI":"10.1192\/bjp.bp.110.084269","article-title":"Age and birth cohort differences in the prevalence of common mental disorder in England: National Psychiatric Morbidity Surveys 1993\u20132007","volume":"198","author":"Spiers","year":"2011","journal-title":"Br. J. Psychiatry J. Mental Sci."},{"key":"10.1016\/j.bbi.2017.11.020_b0295","doi-asserted-by":"crossref","first-page":"e199","DOI":"10.1038\/tp.2012.120","article-title":"Evidence for sustained elevation of IL-6 in the CNS as a key contributor of depressive-like phenotypes","volume":"2","author":"Sukoff Rizzo","year":"2012","journal-title":"Transl. Psychiatry"},{"key":"10.1016\/j.bbi.2017.11.020_b0300","doi-asserted-by":"crossref","first-page":"346","DOI":"10.1016\/j.schres.2008.04.018","article-title":"Association between interleukin-6 receptor polymorphism and patients with schizophrenia","volume":"102","author":"Sun","year":"2008","journal-title":"Schizophrenia Res."},{"key":"10.1016\/j.bbi.2017.11.020_b0125","doi-asserted-by":"crossref","first-page":"1214","DOI":"10.1016\/S0140-6736(12)60110-X","article-title":"The interleukin-6 receptor as a target for prevention of coronary heart disease: a mendelian randomisation analysis","volume":"379","author":"Swerdlow","year":"2012","journal-title":"Lancet"},{"key":"10.1016\/j.bbi.2017.11.020_b0305","doi-asserted-by":"crossref","first-page":"1055","DOI":"10.1007\/s10067-014-2609-z","article-title":"Responsiveness of the EuroQol EQ-5D and Hospital Anxiety and Depression Scale (HADS) in rheumatoid arthritis patients receiving tocilizumab","volume":"33","author":"Traki","year":"2014","journal-title":"Clin. Rheumatol."},{"key":"10.1016\/j.bbi.2017.11.020_b0310","doi-asserted-by":"crossref","first-page":"101","DOI":"10.1016\/j.schres.2014.03.005","article-title":"Cytokine function in medication-naive first episode psychosis: a systematic review and meta-analysis","volume":"155","author":"Upthegrove","year":"2014","journal-title":"Schizophrenia Res."},{"key":"10.1016\/j.bbi.2017.11.020_b0315","unstructured":"Wechsler, D., Golombok, S., Rust, J., 1992. Weschler Intelligence Scale for Children (3rd Edition) (WISC\u2013III UK). The Psychological Corporation."},{"key":"10.1016\/j.bbi.2017.11.020_b0320","series-title":"The ICD-10 Classification of Mental and Behavioural Disorder: Clinical Descriptions and Disgnostic Guidelines","author":"WHO","year":"1992"},{"key":"10.1016\/j.bbi.2017.11.020_b0325","series-title":"SCAN: Schedules for Clinical Assessment in Neuropsychiatry Version 2.0.","author":"WHO","year":"1994"},{"key":"10.1016\/j.bbi.2017.11.020_b0330","doi-asserted-by":"crossref","first-page":"722","DOI":"10.1016\/j.pnpbp.2009.03.020","article-title":"Higher plasma interleukin-6 (IL-6) level is associated with SSRI- or SNRI-refractory depression","volume":"33","author":"Yoshimura","year":"2009","journal-title":"Progr. Neuro-psychopharmacol. Biol. Psychiatry"},{"key":"10.1016\/j.bbi.2017.11.020_b0335","doi-asserted-by":"crossref","first-page":"742","DOI":"10.1176\/appi.ajp.2013.12060768","article-title":"Psychotic experiences and psychotic disorders at age 18 in relation to psychotic experiences at age 12 in a longitudinal population-based cohort study","volume":"170","author":"Zammit","year":"2013","journal-title":"Am. J. Psychiatry"}],"container-title":["Brain, Behavior, and Immunity"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0889159117305214?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0889159117305214?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,11]],"date-time":"2025-10-11T07:48:16Z","timestamp":1760168896000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0889159117305214"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2018,3]]},"references-count":67,"alternative-id":["S0889159117305214"],"URL":"https:\/\/doi.org\/10.1016\/j.bbi.2017.11.020","relation":{},"ISSN":["0889-1591"],"issn-type":[{"value":"0889-1591","type":"print"}],"subject":[],"published":{"date-parts":[[2018,3]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Association between a functional interleukin 6 receptor genetic variant and risk of depression and psychosis in a population-based birth cohort","name":"articletitle","label":"Article Title"},{"value":"Brain, Behavior, and Immunity","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.bbi.2017.11.020","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2017 The Author(s). Published by Elsevier Inc.","name":"copyright","label":"Copyright"}]}}